Compare Ralph Lauren Corp (RL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ralph Lauren Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Ralph Lauren Corp trades at $375.67 (market cap $22.41B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Ralph Lauren Corp pays a 0.99% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Ralph Lauren Corp nearer its low. Which is the better fit depends on your goals.
| RL | XBI | |
|---|---|---|
Market Cap | $22.41B | — |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $414.25 | $164.28 |
52-Week Low | $283.34 | $85.16 |
Enterprise Value | $23.35B | — |
Dividend Yield | 0.99% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ralph Lauren Corp
Founded by designer Ralph Lauren in 1967, Ralph Lauren Corp. designs, markets, and distributes lifestyle products in North America, Europe, and Asia. Its products include apparel, footwear, eyewear, jewelry, leather goods, home products, and fragrances. The company's brands include Ralph Lauren Collection, Polo Ralph Lauren, Lauren Ralph Lauren, and Double RL. Distribution channels for Ralph Lauren include wholesale (including department stores and specialty stores), retail (including company-owned retail stores and e-commerce), and licensing.
Read more on RL →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
